USRMU.S. Stem Cell, Inc.

About U.S. Stem Cell, Inc. (USRM)

U.S. Stem Cell, Inc. (USRM) is a Biotechnology company headquartered in Sunrise, FL, United States whose shares trade over-the-counter on the Expert Market tier.

Founded in 1999, U.S Stem Cell, Inc. is committed to the development of effective cell technologies to treat a variety of diseases and injuries. By harnessing the body's own healing potential, we may be able to reverse damaged tissue to normal function. U.S. Stem Cell's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle. U.S Stem Cell is focused on regenerative medicine. While most stem cell companies use one particular cell type to treat a variety of diseases, U.S Stem Cell utilizes various cell types to treat different diseases. It is our belief that the unique qualities within the various cell types make them more advantageous to treat a particular disease.

Products and services

The business includes the development of proprietary cell therapy products as well as revenue generating physician and patient-based regenerative medicine/cell therapy training services, cell collection and cell storage services, and the sale of cell collection and treatment kits for humans and animals. US Stem Cell Training, Inc. (“SCT”), an operating division of our company, is a content developer of regenerative medicine/cell therapy informational and training materials for physicians and patients. SCT also provides in-person and online training courses which are delivered through in-person presentations at SCT’s state of the art facilities and globally at university, hospital and physician’s office locations as well as through online webinars. Additionally, SCT provides hands-on clinical application training for physicians and health care professionals interested in providing regenerative medicine / cell therapy procedures. Vet biologics, (“VBI”), an operating division of our company, is a veterinary regenerative medicine company committed to providing veterinarians with the ability to deliver the highest quality regenerative medicine therapies to dogs, cats and horses. VBI provides veterinarians with extensive regenerative medicine capabilities including the ability to isolate regenerative stem cells from a patient’s own adipose (fat) tissue directly on-site within their own clinic or stall-side.

USRM key facts

Ticker symbol

USRM

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Sunrise, FL, United States

Country of incorporation

US

Employees

3

Estimated market cap

$66.2K (as of Apr 11, 2025)

Shares outstanding

661,507,317

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

U.S. Stem Cell, Inc. leadership

• Miguel Tomas — President, CEO
• Jill Arlene Robbins — Counsel

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with U